About IQVIA Holdings Inc.
https://www.iqvia.comIQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.
CEO
Ari Bousbib
Compensation Summary
(Year 2024)
ETFs Holding This Stock
Summary
Showing Top 3 of 752
Ratings Snapshot
Rating : B+
Most Recent Analyst Grades
Grade Summary
Showing Top 6 of 14
Price Target
Institutional Ownership
VANGUARD GROUP INC
Shares:19.49M
Value:$4.7B
BLACKROCK INC.
Shares:15.23M
Value:$3.68B
BLACKROCK, INC.
Shares:14.79M
Value:$3.57B
Summary
Showing Top 3 of 1,249
About IQVIA Holdings Inc.
https://www.iqvia.comIQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $4.1B ▲ | $820M ▲ | $331M ▲ | 8.07% ▲ | $1.94 ▲ | $883M ▲ |
| Q2-2025 | $4.02B ▲ | $817M ▲ | $266M ▲ | 6.62% ▲ | $1.55 ▲ | $781M ▲ |
| Q1-2025 | $3.83B ▼ | $802M ▲ | $249M ▼ | 6.5% ▼ | $1.42 ▼ | $753M ▼ |
| Q4-2024 | $3.96B ▲ | $752M ▼ | $437M ▲ | 11.04% ▲ | $2.44 ▲ | $1.02B ▲ |
| Q3-2024 | $3.9B | $828M | $285M | 7.32% | $1.57 | $797M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $1.97B ▼ | $28.73B ▲ | $22.44B ▼ | $6.16B ▲ |
| Q2-2025 | $2.19B ▲ | $28.63B ▲ | $22.85B ▲ | $5.78B ▼ |
| Q1-2025 | $1.88B ▲ | $27.32B ▲ | $21.34B ▲ | $5.98B ▼ |
| Q4-2024 | $1.84B ▲ | $26.9B ▼ | $20.83B ▲ | $6.07B ▼ |
| Q3-2024 | $1.71B | $27.18B | $20.21B | $6.97B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $332M ▲ | $908M ▲ | $-550M ▼ | $-572M ▼ | $-225M ▼ | $1.2B ▲ |
| Q2-2025 | $266M ▲ | $443M ▼ | $-346M ▼ | $145M ▲ | $299M ▲ | $292M ▼ |
| Q1-2025 | $249M ▼ | $568M ▼ | $-305M ▲ | $-258M ▲ | $38M ▼ | $426M ▼ |
| Q4-2024 | $437M ▲ | $885M ▲ | $-310M ▲ | $-375M ▼ | $130M ▲ | $721M ▲ |
| Q3-2024 | $285M | $721M | $-599M | $-137M | $27M | $571M |
Revenue by Products
| Product | Q3-2024 | Q4-2024 | Q1-2025 | Q3-2025 |
|---|---|---|---|---|
 Contract Sales And Medical Solutions | $180.00M ▲ | $180.00M ▲ | $180.00M ▲ | $210.00M ▲ |
 Research And Development Solutions | $2.16Bn ▲ | $2.12Bn ▼ | $2.10Bn ▼ | $2.26Bn ▲ |
 Technology And Analytics Solutions | $1.55Bn ▲ | $1.66Bn ▲ | $1.55Bn ▼ | $1.63Bn ▲ |
Revenue by Geography
| Region | Q4-2024 | Q3-2024 | Q3-2025 | Q1-2025 |
|---|---|---|---|---|
 Americas | $1.85Bn ▲ | $1.84Bn ▼ | $1.93Bn ▲ | $1.81Bn ▼ |
 Asia Pacific | $810.00M ▲ | $770.00M ▼ | $870.00M ▲ | $800.00M ▼ |
 EMEA | $1.30Bn ▲ | $1.29Bn ▼ | $1.30Bn ▲ | $1.22Bn ▼ |
CEO
Ari Bousbib
Compensation Summary
(Year 2024)
ETFs Holding This Stock
Summary
Showing Top 3 of 752
Ratings Snapshot
Rating : B+
Most Recent Analyst Grades
Grade Summary
Showing Top 6 of 14
Price Target
Institutional Ownership
VANGUARD GROUP INC
Shares:19.49M
Value:$4.7B
BLACKROCK INC.
Shares:15.23M
Value:$3.68B
BLACKROCK, INC.
Shares:14.79M
Value:$3.57B
Summary
Showing Top 3 of 1,249